FiercePharma

Merck escapes nearly 1,200 Zostavax shingles vaccine lawsuits as plaintiffs' testimony falls short

Following a court judgment in its favor last year, Merck & Co. is formally bidding adieu to more than 1,000 lawsuits alleging its shingles vaccine Zostavax caused patients to develop the disease.
FiercePharma

Merck puts 1,000-plus Zostavax lawsuits to bed after plaintiffs file for dismissal

After a drawn-out litigation process, Merck & Co. seems to have finally washed its hands of more than a thousand lawsuits tied to its shingles vaccine Zostavax. Late last week, the U.S. Court of ...
Nasdaq

Column: Merck shingles vaccine appeal will test controversial mass torts case management tool

Oct 18 (Reuters) - The federal trial judge overseeing a four-year-old multidistrict litigation over Merck’s Zostavax shingles vaccine decided in March 2022 that it was time for plaintiffs to put up or ...
Benzinga.com

Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits

Merck & Co Inc (NYSE:MRK) has reportedly secured a significant legal victory as the 3rd U.S. Circuit Court of Appeals upheld the dismissal of nearly 1,200 lawsuits concerning its Zostavax shingles ...
NJBIZ

FDA Extends Review Date for Merck’s Shingles Vaccine

The Merck vaccine is a regimen designed to prevent the onset of shingles, which is caused by the reemergence of dormant chicken pox virus.The U.S. Food and Drug Administration (FDA) has extended the ...